NeuroOne raises ~$2.65M in private placement and secures $3M debt facility

NEUROONE MEDICAL TECHNOLOGIES Corp

Private placement of 2,944,446 shares and warrants for 2,208,333 shares at $0.90/unit, gross ~$2.65M.
Closed Aug 2, 2024. Proceeds for operations, commercial expansion, product development, and strategic partner diligence.
Also entered $3M delayed-draw term loan from Growth Opportunity Funding at 10% interest, maturing Feb 2, 2026.
Lender received warrant for 100,000 shares at $0.66, plus additional warrants upon draws.
Director Paul Buckman participated in private placement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.